Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Level of Myeloperoxidase Expression as a Crucial Determinant of Sensitivity of Myeloid Leukemia Cells to Parthenolide-Induced Apoptosis

Soo Jeong Kim, M.D., Ju In Eom, Hye Won Lee, M.D., Hoi Kyung Jeung, Jin Seok Kim, M.D., Ph.D., Yoo-Hong Min, M.D., Ph.D.

Blood (2008) 112 (11): 2945.

https://doi.org/10.1182/blood.V112.11.2945.2945

Published: 2008

Journal Articles

Aurora Kinase Inhibition Enhances the Chemotherapy-Induced Myeloid Leukemia Cell Death through Different Mechanism According to the Chemotherapeutic Agents

Soo Jeong Kim, M.D., Haeng Im Jung, Hye Won Lee, M.D., Jin Seok Kim, M.D., Ph.D., Yoo-Hong Min, M.D., Ph.D.

Blood (2008) 112 (11): 2644.

https://doi.org/10.1182/blood.V112.11.2644.2644

Published: 2008

Journal Articles

mTOR Inhibitor Rapamycin Interacts Synergistically with Farnesyltransferase Inhibitor FTI-277 To Induce Growth Inhibition in Human Leukemia Cells.

June-Won Cheong, MD, PhD, Ju In Eom Eom, Hye Won Lee, M.D., In-Hae Park, M.D., Yuri Kim, M.D., Jin Seok Kim, M.D., Ph.D., Yoo-Hong Min, M.D., Ph.D.

Blood (2007) 110 (11): 1821.

https://doi.org/10.1182/blood.V110.11.1821.1821

Published: 2007

Journal Articles

Ligation of CD44 by A3D8 Monoclonal Antibody Induces Terminal Differentiation of THP-1 Leukemia Cells by Promoting Cross-Talk between Extracellular Signal-Regulated Kinase and Phosphoinositide-3 Kinase/Akt Signaling Pathway.

Yoo-Hong Min, M.D., Ph.D., Ji Yeon Kim, Hoi Kyung Jeung, Seung Tae Lee, M.D., Ph.D, June-Won Cheong, M.D.

Blood (2004) 104 (11): 4460.

https://doi.org/10.1182/blood.V104.11.4460.4460

Published: 2004

Journal Articles

Akt/PKB Activation-Induced Cytoplasmic Mislocalization of p27Kip1 Protein Is Mediated by Jab1 Shuttling in Human Myeloid Leukemia Cells.

Yoo-Hong Min, M.D., Ph.D., Ju In Eom, Ae Jin Choi, Jee Young Lee, Jin Seok Kim, M.D., Seung Tae Lee, M.D., June-Won Cheong, M.D.

Blood (2004) 104 (11): 4461.

https://doi.org/10.1182/blood.V104.11.4461.4461

Published: 2004

NARROW

Level of Myeloperoxidase Expression as a Crucial Determinant of Sensitivity of Myeloid Leukemia Cells to Parthenolide-Induced Apoptosis

Aurora Kinase Inhibition Enhances the Chemotherapy-Induced Myeloid Leukemia Cell Death through Different Mechanism According to the Chemotherapeutic Agents

mTOR Inhibitor Rapamycin Interacts Synergistically with Farnesyltransferase Inhibitor FTI-277 To Induce Growth Inhibition in Human Leukemia Cells.

Ligation of CD44 by A3D8 Monoclonal Antibody Induces Terminal Differentiation of THP-1 Leukemia Cells by Promoting Cross-Talk between Extracellular Signal-Regulated Kinase and Phosphoinositide-3 Kinase/Akt Signaling Pathway.

Akt/PKB Activation-Induced Cytoplasmic Mislocalization of p27Kip1 Protein Is Mediated by Jab1 Shuttling in Human Myeloid Leukemia Cells.

Email alerts

ASH Publications

American Society of Hematology

Level of Myeloperoxidase Expression as a Crucial Determinant of Sensitivity of Myeloid Leukemia Cells to Parthenolide-Induced Apoptosis

Aurora Kinase Inhibition Enhances the Chemotherapy-Induced Myeloid Leukemia Cell Death through Different Mechanism According to the Chemotherapeutic Agents

mTOR Inhibitor Rapamycin Interacts Synergistically with Farnesyltransferase Inhibitor FTI-277 To Induce Growth Inhibition in Human Leukemia Cells.

Ligation of CD44 by A3D8 Monoclonal Antibody Induces Terminal Differentiation of THP-1 Leukemia Cells by Promoting Cross-Talk between Extracellular Signal-Regulated Kinase and Phosphoinositide-3 Kinase/Akt Signaling Pathway.

Akt/PKB Activation-Induced Cytoplasmic Mislocalization of p27Kip1 Protein Is Mediated by Jab1 Shuttling in Human Myeloid Leukemia Cells.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only